Loomis Sayles & CO L P Sutro Biopharma, Inc. Transaction History

Loomis Sayles & CO L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$7.78 - $15.31 $8.68 Million - $17.1 Million	-1,115,835 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$14.25 - $23.53 $6.47 Million - $10.7 Million	-453,970 Reduced 28.92%	1,115,835 $16.6 Million
Q3 2021 Nov 12, 2021	BUY	$16.88 - $22.38 $4.08 Million - $5.41 Million	241,791 Added 18.21%	1,569,805 $29.7 Million
Q2 2021 Aug 13, 2021	SELL	$18.03 - $23.82 $486,431 - $642,639	-26,979 Reduced 1.99%	1,328,014 $24.7 Million
Q1 2021 May 17, 2021	BUY	$20.29 - $27.54 $27.5 Million - $37.3 Million	1,354,993 New	1,354,993 $30.8 Million

122

53.3M

7.8K

2.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $153M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.